Cynthia Kozakiewicz

Special Counsel
Full contact info


DBV Technologies Completes Concurrent Public Offerings

November 6, 2014

Cooley advised the underwriters on DBV Technologies' concurrent $106.4 million initial public offering and $28.3 million secondary public offering on Euronext.

DBV Technologies is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The company trades on the Nasdaq Global Market under the symbol "DBVT" and on Euronext under the symbol "DBV."

Citigroup Global Markets, Leerink Partners and Bryan, Garnier & Co. acted as joint global coordinators and joint book running managers of the global offering.

Related contacts

Marc Recht
Partner, Boston
Div Gupta
Partner, New York
Brian Leaf
Partner, Reston
Barbara Kosacz
Senior Counsel, Palo Alto
Natasha Leskovsek
Of Counsel, Washington, DC
Scott Weston
Partner, Boston
Tamim Bazzi
Partner, New York
Danielle Gershowitz
Partner, New York
Phil Mitchell
Partner, New York
Cynthia Kozakiewicz
Special Counsel, Boston

Related Practices & Industries

Admissions & credentials


US Patent and Trademark Office